Search - tctmd.com

Displaying 1 - 20 of 48

Sort: Relevancy | Date

News Conference News TCT 2024

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

Yael L. Maxwell

October 29, 2024

News Daily News

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Michael O'Riordan

September 15, 2023

News Daily News

More Data Show Redlining’s Lasting Impact on CVD Risk

L.A. McKeown

July 14, 2023

News Daily News

Interventional Cardiology Training Needs Defined for the First Time

Yael L. Maxwell

February 20, 2023

Cath Labs Trying to Get Back on Track With Documentation, Quality Measures

News Conference News SCAI 2022

Cath Labs Trying to Get Back on Track With Quality Measures, Documentation

L.A. McKeown

May 27, 2022

News Conference News ACC 2022

Better Angina Relief With Complete PCI in STEMI and MVD

L.A. McKeown

April 02, 2022

News Conference News SCAI 2021

Cardiogenic Shock: Protocols, Clear Definitions Advance the Field

Caitlin E. Cox

April 30, 2021

News Daily News

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Michael O'Riordan

November 03, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Daily News

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Michael O'Riordan

December 10, 2019

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

News Conference News EuroPCR 2019

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

L.A. McKeown

May 22, 2019

News Daily News

Bariatric Surgery Linked to Survival Advantage After MI and CVA

Michael O'Riordan

May 13, 2019

News Conference News ACC 2019

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

Michael O'Riordan

March 21, 2019

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2018

Caitlin E. Cox

April 30, 2018

News Daily News

Impella Use in Acute MI and Cardiogenic Shock: Clues From US Registry Data

Caitlin E. Cox

April 12, 2018

News Daily News

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

Leah Lawrence

July 24, 2017

News Features

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Michael O'Riordan

May 23, 2017

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

Advertisement

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

More Data Show Redlining’s Lasting Impact on CVD Risk

Interventional Cardiology Training Needs Defined for the First Time

Cath Labs Trying to Get Back on Track With Quality Measures, Documentation

Better Angina Relief With Complete PCI in STEMI and MVD

Cardiogenic Shock: Protocols, Clear Definitions Advance the Field

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

Bariatric Surgery Linked to Survival Advantage After MI and CVA

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

TCTMD’s Top 10 Most Popular Stories for April 2018

Impella Use in Acute MI and Cardiogenic Shock: Clues From US Registry Data

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content